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Abstract Muscle phosphofructokinase interacts with microtu- 
hule-associated protein-free microtubules resulting iu a reduction 
of the overall activity of the enzyme [Lehotzky et al. (1993) 
J. Biol. Chem. 268,10888-108941 and periodical cross-linking of 
the tubules [Lehotzky et al. (1994) Biochem. Biophys. Res. Com- 
mun. 204, 585-5911. Microtubule polymers of ‘tail-free’ tubulin 
obtained by removal of the carboxy-termini with limited subtilisin 
digestion retain the binding domains for phosphofructokinase that 
cross-bridges microtubule ‘bodies’. Microtubule-associated pro- 
teins bound on tubulin ‘tails’ do not perturb the kinase binding. 
These data suggest that the tnbuliu carboxy-terminal domain is 
not involved in microtubule-phosphofructokinase interactions and 
phosphofructokinase and microtubule-associated proteins have 
distinct binding domains on microtubules. Of different isoforms 
of phosphofructokinase, occurring mainly in brain and tumor 
cells, the muscle isoform exhibits selective adsorption behaviour 
on microtubules. Phosphofructokinase M and C isoforms with 
different associative and allosteric properties may represent an 
auxiliary pathway to modulate energy production via glycolysis. 
Key words: Phosphofructokinase; Microtubule; Microtubule- 
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1. Introduction 
Microtubules (MTs), polymers of tubulin heterodimers, are 
ubiquitous cellular structures involved in several essential func- 
tions of the cell, including modulation of cell shape, intracellu- 
lar transport of organelles, motility, secretion and cell division 
[l]. The tubulin heterodimer is composed of a and j? subunits, 
each possesses an amino-terminal domain and a carboxy-termi- 
nal domain whose extreme end is highly charged. Limited sub- 
tilisin treatment cleaves the small carboxy-terminal fragments 
(molecular mass ~2 kDa) from both subunits, resulting in a 
derivative of substantially altered assembly properties [2]. The 
cleaved, less acidic protein retains its competence to polymerize 
with a critical concentration for assembly about 50-fold lower 
than that for intact tubulin. It was proposed that carboxy- 
termini of the subunits normally impede polymerization [2]. 
Electron microscopy of negatively stained samples showed [2] 
that the cleaved protein forms ordered array of filaments which 
are different from MTs in that they are not closed and show 
clear cross-striations. 
The stability and spatial arrangement of the tubules are reg- 
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ulated by microtubule-associated proteins (MAPS), predomi- 
nanly MAP-2 and tau which contain common sequences in 
tubulin binding sites [3], and interact with the C-terminal do- 
main of tubulin [4] that is exposed on the surface of tubules. 
Extensive binding of many, but not all glycolytic enzymes 
purified from muscle to the tubulin/MTs system has been doc- 
umented [.5,6,7]. In addition, association of several glycolytic 
enzymes from brain homogenate or synaptosomes has been 
reported, however, only phosphofructokinase (PFK) showed 
considerable association even at physiological salt concentra- 
tion. In in vivo experiments PFK has been identified in axonal 
transport as slow component b (SCb) with several other en- 
zymes of intermediary metabolism which are organized as a 
discrete macromolecular cellular entity [8,9]. Associations of 
glyceraldehyde phosphate dehydrogenase and PFK with MAP- 
free MTs appear to have ‘functional duality’ in which the over- 
all activities of the enzymes are modulated as well as the ultra- 
structure of MTs is altered [10,11,12,13,14]. Electron micro- 
scopic studies provided direct evidence for the periodical cross- 
bridges of MTs by PFK [14]. 
Recent data showed that the acidic C-terminal ‘tail’ of tu- 
bulin was predominantly involved in the binding of aldolase 
[ 15,16,17] and probably glyceraldehyde phosphate dehydroge- 
nase [ 161. The removal of the carboxy-terminal of tubulin heter- 
odimer molecules, organized in MTs, with limited subtilisin 
digestion decreased significantly aldolase binding and aldolase 
inhibited subtilisin-catalyzed cleavage of the C-terminal [ 1 S]. 
The C-terminal ‘tail’ of both tubulin subunits is rich in acidic 
amino acids, thus it is highly charged at physiological pH and 
exposed in an extended conformation. Most glycolytic enzymes 
are ‘basic’ proteins with isoelectric points around 8 [18] and 
electrostatic forces are predominantly involved in the heterolo- 
gous interactions. PFK is an exception concerning its relatively 
low isoelectric point that questions the role of the acidic tubulin 
‘tail’ in the binding of PFK. 
All these data refer to the muscle isoform of PFK whereas 
in certain vertebrate tissues the kinase and some other glyco- 
lytic enzymes exist as series of multiple forms. The brain pos- 
sesses a complex mixture of homotetramers and hybrids [19]. 
Three isoforms of PFK exist: C (brain type), M (muscle type) 
and L (liver type) [20] that are easily resolvable by SDS-PAGE. 
In normal adult brain, the M-C hybrids of PFK are predomi- 
nant with a small amount of M-L. The C isoform, found in 
relatively high ratio in tumor cells, possesses altered allosteric 
properties in comparison to the muscle-type M isoform [20,21]. 
The hybrids may produce properties which are intermediate or 
similar to those found for homotetramers. 
In this study we provide evidence against the direct involve- 
ment of the tubulin carboxy-terminal ‘tails’ as well as that of 
the MAPS in PFK binding to MTs. Differential binding behav- 
iour of the brain PFK isoforms is demonstrated as well. 
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2. Materials and methods 
Rabbit muscle PFK, GTP, phenylmethylsulfonyl fluoride and taxol 
were from Sigma, other chemicals were reagent-grade commercial prep- 
arations. The crystalline suspension of rabbit muscle PFK was centri- 
fuged at 10,000 x g for 5 min, the pellet was suspended in 50 mM 
2-(N-morpholino)ethane sulfonic acid (MES), pH 6.8, containing 100 
mM KCl, 1 mM MgC&, 2 mM dithioerythritol and 1 mM EGTA 
(standard buffer). The enzyme solution was then dialyzed against the 
same buffer. PFK from bovine brain was purified by ATP-Sepharose 
affinity chromatography as described in [22] and stored in the presence 
of 50% (v/v) glycerol at - 80°C. Aliquots of brain PFK were dialyzed 
against standard buffer before use. MAP-free tubulin from bovine 
brain was purified using the Weisenberg method modified by Na and 
Timasheff [23]. MAP-containing MTs were purified from bovine brain 
by the taxol-stabilizing method of Vallee [24]. The preparation con- 
tained MAPS of high molecular mass (MAP1 and MAPZ) as visualized 
on SDS-PAGE gels. 
Concentrations of muscle PFK and tubulin were determined spectro- 
photometrically (using the coefficients A0 ” = 1.07 at 280 nm [is] and 
A”.‘% = 1.03 at 276 nm 1231. resuectivelv. For calculations of molar 
concentration of muscle PF-i, tie subunit molecular mass of 83 kDa 
was used [26]. Muscle PFK molar concentration is always given in 
monomers. Concentrations of brain PFK and MAP-containing or 
MAP-free MTs were determined by Bradford’s assay [27] using the 
BioRad kit with bovine serum albumin as standard. Protein purity and 
the composition of pellet and supernatant fractions were determined by 
discontinous SDS-PAGE [28]. In some cases, gel electrophoresis was 
conducted according to [2], to obtain separation of a and /3 tubulin 
subunits. 
Polymerization of MAP-free tubulin was induced in 50 mM 2-(N- 
morpholino)ethane sulfonic acid pH 6.8 buffer with 2 mM 
dithioerythritol. The tubulin solution (at 6-10 mg/ml concentration) 
was dialyzed overnight in the cold room against the above buffer, was 
warmed to 37”C, and taxol was added to a final concentration of 20 
PM. After 30 min incubation at 37”C, MTs were pelleted for 25 min 
by 100,000 x g centrifugation at 30 “C. Microtubules were resuspended 
in standard buffer to a concentration of 2 mg/ml, as determined by 
Bradford’s assay [27]. 
Subtilisin digestion of MAP-free MTs was performed under limiting 
conditions (2 mg/ml MT, 1% (w/w) subtilisin, 140 min incubation at 
30°C) [29] in standard buffer but in the absence of 100 mM KCI and 
in the presence of 1 mM GTP. Digestion was stopped by the addition 
of 1 mM phenylmethylsulfonyl fluoride. Digested MTs were centri- 
fuged (25 min at 100,000 x g, at 30”(Z), pellet was resuspended to the 
starting volume in standard buffer and used in binding experiments. 
When the effect of muscle PFK on kinetics of subtilisin digestion of 
12 34 56 
Fig. 1. Electrophoretic analysis of binding of muscle PFK to native and 
digested MTs. Samples were prepared as in section 2, aliquots were 
applied on 9% polyacrylamide gels. PFK concentration was 2.4 PM in 
the binding experiments. Lane 1, native MT; lane 2, digested MT; lanes 
3 and 4, supernatant and pellet fractions of native MT-PFK mixtures, 
respectively; lanes 5 and 6, supernatant and pellet fractions of digested 
MT-PFK mixtures, respectively. Row A, PFK; row B, native tubulin 
a and /? subunits; row C and D, digested a- and p-tubulin, respectively. 
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Fig. 2. Binding of muscle PFK to native (open symbols) and subtilisin 
treated (closed symbols) MTs. Data were obtained by densitometric 
analysis of pelleting experiments similar to those presented in Fig. 1. 
Abscissa is the PFK concentration in the incubation mixtures, ordinate 
gives [PFK] in the resuspended pellet, i.e. [PFKlbound. Error of the 
densitometric determination was typically 10% for both data sets, as 
measured from three independent binding experiments at each PFK 
concentration. 
MTs was studied, the above procedure was modified. 1 mg/ml MT was 
preincubated (30 min, 30°C) in the absence or presence of 1 mg/ml(l2 
PM in monomers) muscle PFK in standard buffer. Subtilisin was added 
to 1% (w/w) and aliquots were removed at different time points, diges- 
tion was stopped as above, and samples were analyzed by SDS-PAGE. 
Binding (pelleting) experiments with muscle or brain PFK and MTs 
(MAP-free or MAP-containing intact MTs or digested MTs) were 
carried out by coincubation (30 min at 30°C) of the enzyme (O.lUl.8 
mg/ml) with MTs (1 mg/ml), followed by pelleting -(25 min at 
100,000 x p at 30°C). Sunernatant and uellet fractions were seoarated. 
pellet was iesuspended to starting volume and fractions were analyzed 
by densitometry of SDS-PAGE gels [13] using the BioRad GelDoc 1000 
densitometer with the Molecular Analyst sofware. 
For electron microscopic measurements, the pellets were fixed in 0.1 
M sodium cacodylate (pH 7.4) containing 2% glutaraldehyde and 0.2% 
tannic acid for 1 hour at room temperature [14]. After washing with 
sodium cacodylate, the samples were postfixed with 0.5% 0~0, in 0.1 
M sodium cacodylate for 30 min, stained with 1% uranyl acetate, 
dehydrated in graded ethanol and embedded in Durcupan (Fluca, 
Basel). Thin sections were contrasted with uranyl acetate and lead 
citrate and examined in a JEOL CX 100 electron microscope at an 
accelerating voltage of 80 kV. 
3. Results and discussion 
3.1. Association of’ PFK with ‘tail-free MTs 
Limited digestion of tubulin or MTs with subtilisin results in 
one cleavage at the carboxy-termini of both a- and B-subunits 
[2,15,29]. In our experiments we reproduced these results: diges- 
tion led to the appearance of two well separated bands at the 
expected molecular weight on SDS-PAGE with no significant 
smaller fragments (Fig. 1). In order to measure PFK binding 
to native and digested MTs, pelleting experiments were carried 
out [13]. Due to the relative large size of MT, at centrifugation 
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speed of 100,000 x g, MTs were pelleted with the bound en- 
zyme, and the unbound enzyme appeared in the supematant. 
Fig. 1 shows a characteristic gel pattern of a typical pelleting 
experiments carried out with digested and native MTs, as well. 
The pellets in both cases contain all MTs, visualised at molec- 
ular mass of - 50 kDa corresponding to tubulin subunits, as well 
as most of PFK with subunit molecular mass of 83 kDa. Fig. 
2 summarizes the quantitative data obtained at six different 
PFK concentrations with the intact and digested MTs by den- 
sitomeric analysis of the samples after SDS gel separation. 
There is virtually no difference between the data sets indicating 
that the tubulin carboxy domain is not the primary target of 
PFK binding. 
This result is supported by another set of experiments in 
which the kinetics of MT digestion by subtilisin was followed 
in the absence and presence of PFK. The data of densitometric 
analysis of SDS-PAGE gels showed that PFK binding to MTs 
does not perturb the cleavage of the carboxy-terminal ‘tails’ 
exposed on MTs (data not shown). 
Results of electron microscopic examinations of subtilisin- 
digested MT samples are in good agreement with the data of 
binding experiments. The pellets in the absence of PFK consist 
of randomly arranged smooth walled MTs (cf. Fig. 3a) with 
morphology similar to that of undigested MTs described in 
detail in our previous work [14]. This result is in agreement with 
[29]. On the other hand, addition of PFK to the subtilisin- 
digested MTs results in the appearance of groups of parallely 
aligned MTs connected by rows of periodic lateral arms (cf. 
Fig. 3b). Our results clearly show that if the C-terminal tubulin 
‘tails’ were selectively removed from MTs then the overall 
structure of tubules is similar to the native one and modified 
MTs still form PFK-dependent bundles. Therefore, these re- 
sults exclude the direct and dominant role of tubulin C-terminal 
‘tails’ in the PFK binding. 
Aldolase is a sequential enzyme to PFK in glycolysis that 
binds MT [30,3 11. Knull and coworker [15] found that the 
removal of the tubulin carboxy-terminal peptide from MTs 
with limited subtilisin digestion decreased significantly the 
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amount of aldolase copelleted with MAP-free MTs. Aldolase 
possesses net positive charge at physiological pH values, and 
complexation of aldolase and MTs is dramatically decreased by 
increasing the salt concentration up to the physiological one. 
Critical involvement of the acidic tubulin C-terminal in the 
aldolase-MT complex emphasizes the role of ionic interactions. 
Our present data suggest that other types of the interacting 
forces are involved in the complex formation between PFK and 
MTs that are virtually insensitive to the physiological ionic 
strength. 
3.2. MAPS are not involved in the PFK binding 
Several reports suggest the involvement of the charged tu- 
bulin C-terminal in MAPS binding to MTs [4,29,32]. On the 
basis of the results of the binding experiments with ‘tail-free’ 
MTs, it can be hypothesized that distinct domains of MT are 
the targets of PFK and MAPS. Comparative pelleting experi- 
ments were carried out with MAP-free and MAP-containing 
MTs and muscle PFK. A typical gel pattern (Fig. 4, inset) 
shows that the presence of MAPS on MTs does not interfere 
with PFK binding. Quantitative data at different PFK concen- 
trations does not reveal any significant difference in the enzyme 
amount copelleted with MTs (Fig. 4). Thin section electron 
microscopic data illustrate that MTs incubated in the presence 
of MAPS are decorated with dense spots and filamentous pro- 
jections (cf. Fig. 3~). These observations are in good agreement 
with earlier reports showing that MAPS are rod-like molecules 
and that their binding sites are helically arranged along the wall 
of MTs [33]. The dense spots probably represent MAPS ori- 
ented transversally to the plane of section. The MAP-decorated 
MTs are randomly arranged in the pellet and do not form 
bundles. On the other hand, many groups of closely aligned 
MTs connected by lateral projections appear in the samples 
after addition of PFK to the MAP-decorated MTs (cf. Fig. 3d). 
These data provide morphologic evidence that MAP-contain- 
ing MTs can bind PFK in vitro and the presence of MAPS does 
not suppress the MT bundling activity of PFK. In vivo MAPS 
are integrant component of microtubular network, therefore, 
Fig. 3. Electron micrographs of subtilisin-digested (a and b) and MAP-decorated native (c and d) MTs without (a and c) and with (b and d) muscle 
PFK, respectively. Muscle PFK and MT concentration in the incubation mixtures during binding was 2.4 PM and 1 mg/ml, respectively. Note the 
presence of MT bundles connected by rows of lateral projections in the PFK containing samples. Bars: 100 nm. 
194 B.G. Vhtessy et al. IFEBS Letters 379 (1996) 191-195 
6 
1 
0 
123 
0 1 2 3 4 5 6 7 i 
[PFK] added, FM 
Fig. 4. Binding of muscle PFK to MAP-free (open symbols) and MAP- 
containing (closed symbols) MTs. Main panel: Densitometric data ob- 
tained from pelleting experiments (as in inset) are presented in the same 
manner as in Fig. 2. Error of determinations was 10% for the MAP-free 
data set, and 13% for the MAP-containing data set, as measured from 
three independent binding experiments at each PFK concentration. 
Inset: Electrophoretic analysis on 7% polyacrylamide gels of a typical 
MAP-MT preparation (lane 1), and supernatant (lane 2) and pellet 
(lane 3) fractions of a typical binding experiment at muscle PFK con- 
centration of 2.4 PM. Rows A and B, high molecular mass MAP1 and 
MAP2, row C, PFK, row D, tubulin subunits. 
our pioneer observation, that MAP-containing MT does bind 
a glycolytic enzyme is important concerning the physiological 
relevance of the macromolecular enzyme associations. In addi- 
tion, we suggest that PFK is a unique glycolytic enzyme that 
specifically interacts with the MT ‘body’. 
3.3. Selective association of muscle PFK to MAP-containing 
MTs 
The association of muscle PFK to MTs results a significant 
reduction of the overall activity of the kinase [13]. Concerning 
the physiological concentration of PFK [34], it can be expected 
that a significant fraction of the kinase can be complexed by 
MT in brain where MT concentration is especially high. On the 
other hand, brain and tumor cells proceed extensive glycolysis. 
Significant differences in the isoenzyme patterns of glycolytic 
enzymes exist between normal and tumor cells [20]. While indi- 
vidual metabolic roles have been proposed for M and L 
isoforms, no adequate explanation of a unique role for the C 
variant has yet been offered despite extensive studies into the 
catalytic and regulatory properties of the purified enzyme. We 
hypothesized that the C isoform may exhibit different affinity 
to MTs and thus the selective association of PFK isoforms 
could ensure an effective control mechanism for glycolysis. 
The mixture of PFK isoenzymes was isolated from the brain 
extract from which MAP-containing MTs were purified. The 
well-established procedure of the pelleting experiments was ap- 
plied for binding studies (cf. Fig. 5). While in the supernatant 
phase the three isoforms can be visualized, the pellet phase 
contains tubulin subunits with the characteristic MAP bands 
and an additional band corresponding to the muscle isoform 
of PFK (Fig. 5, inset). The ratio of isoforms in our preparation 
and the quantitative binding data (Fig. 5) demonstrate that the 
pellet (bound) phase becomes enriched in M, i.e. MTs can select 
among the individual isoenzymes. The muscle-type (M), but not 
the brain-type (C), isoenzyme extensively binds to MTs, al- 
though M and C isoforms occur in brain in comparable 
amount. Several differences in the properties of C and M forms 
could be responsible for different binding. For example, stabil- 
ities of M, and C, tetrameric structures differ significantly [35]. 
Since we demonstrated that the dimeric form of muscle type 
PFK specifically associates to MTs [13], we now suggest that 
differences in the nature of intersubunit forces may be primarily 
80- 
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Fig. 5. Differential adsorption of PFK isoforms on MAP-containing 
MT. Binding conditions are given in section 2, the concentration of 
brain PFK preparation was 0.2 mg/ml. Main panel: Relative amount 
of isoforms in the brain PFK preparation (open bars) and in the pellet 
phase of binding experiments (closed bars) is shown (100% is the sum 
of the amounts of all the three isoforms). Data were obtained from by 
gel densitometry, mean and error of six replicates are presented. Inset: 
Lane 1, supernatant; lane 2, pellet phase of one typical experiment. 
Rows A and B, high molecular mass MAP1 and MAP2, rows C, M, 
L, PFK C, M and L isoforms, respectively, rows D and E, a- and 
jkubulin, respectively. Electrophoresis was performed on 7% poly- 
acrylamide gels with modifications according to [31]. 
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responsible for the apparent selective association of PFK 
isoforms. 
Specific enzyme associations require biorecognition of the 
enzyme that is based upon surface complementarity. The selec- 
tive association of the inactive, dissociated form of muscle PFK 
to MTs but not the tetrameric form of either muscle or brain 
type isoenzyme provides an example for specific enzyme associ- 
ation that is prerequisite for its occurrence in living cell. The 
binding of muscle isoform of PFK to the microtubular network 
could provide an effective means of regulating the catalytic 
capacity of the enzyme, consequently controlling glycolysis. 
Such a mechanism might be operative in muscle and non- 
muscle cells. In brain and tumor cells where the isoforms of this 
key regulatory enzyme with different associative proper- 
ties occur simultanously. the specific macromolecular associa- 
tions may contribute to adjust glycolytic flux over a wide range. 
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